Concepedia

William Renwick

WR

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2006

Affiliations

The Royal Melbourne Hospital(Current)

Peter MacCallum Cancer Centre

Princess Alexandra Hospital

Western Health

The University of Melbourne

William Renwick is an author at The Royal Melbourne Hospital specializing in medicine, oncology, and hematologic malignancy therapy.

Publications per year

2006–2023

11

Publications

11

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

, , +12

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Thierry Façon, Meletios Α. Dimopoulos, Nathalie Meuleman et al. · Leukemia · 2019 · 230 citations · Full text

, , +17

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Evaluation of Suspected Lymphoma

Daniel Steinfort, Matthew Conron, Alpha Tsui et al. · Journal of Thoracic Oncology · 2010 · 163 citations · Full text

, , +11

Recombinant Activated Factor VII: Treating Postoperative Hemorrhage in Cardiac Surgery

Conrad Bishop, William Renwick, Christopher Hogan et al. · The Annals of Thoracic Surgery · 2006 · 60 citations · Full text

, , +16

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

Mark Hertzberg, Maher K. Gandhi, Judith Trotman et al. · Haematologica · 2016 · 57 citations · Full text

, , +12

1–5 of 11